Agenus to Provide Fourth Quarter and Year-end 2025 Financial Report and Corporate Update

Core Viewpoint - Agenus Inc. is set to release its fourth quarter and year-end 2025 financial results on March 16, 2026, before market opening, indicating a focus on transparency and stakeholder engagement [1] Financial Results Announcement - The financial results will be disclosed before the market opens on March 16, 2026, highlighting the company's commitment to timely reporting [1] - A stakeholder briefing webcast will be held in late March to discuss strategic plans and data milestones [1] Development Programs - The company will provide updates on the global development programs for botensilimab (BOT) and balstilimab (BAL), which are key components of its immuno-oncology portfolio [1]